CONTACT US: Contact info
|
Citation |
Galfalvy H, Huang YY, Oquendo MA, Currier D, Mann JJ. J. Affect. Disord. 2009; 115(3): 331-338. |
|
Affiliation |
Division of Molecular Imaging and Neuropathology, Department of Psychiatry, Columbia University,; and New York State Psychiatric Institute, New York, NY, USA. |
|
Copyright |
(Copyright © 2009, Elsevier Publishing) |
|
DOI |
|
PMID |
18977032 |
|
Abstract |
BACKGROUND: The tryptophan hydroxylase 1 (TPH1) gene is reported to be associated with suicidal behavior. This has not been confirmed by prospective studies of suicide and clinical or biological mediators of this genetic risk have not been identified. METHODS: 343 subjects (Caucasian, African-American, Hispanic) presenting with a Major Depressive Episode were genotyped for polymorphisms A218C in intron 7 and A-6526G in the promoter region of TPH1, and monitored for suicide attempts for up to one year. Clinical correlates of suicidal behavior and CSF-HIAA, HVA and MHPG levels were explored as possible mediators of genetic risk. Analyses were adjusted for ethnicity. RESULTS: The AA genotype on intron 7 and the GG genotype on the promoter (both more prevalent in Caucasians) predicted suicide attempts during the 1 year follow-up, and were associated with past attempts of high medical lethality, regardless of ethnicity. The intron 7 genotype was associated with fewer reported reasons for living, and lower impulsivity. Haplotype analysis indicated significant increase in risk of suicide attempts for subjects with four risk alleles. TPH1 genotype was not associated with CSF metabolite levels. LIMITATIONS: The TPH1 gene is likely one of several genes associated with suicidal behavior. Power to detect differential genotype effects by ethnicity is low. CONCLUSIONS: Polymorphisms of TPH1 may assist in identifying a subgroup of mood disorder patients that is at higher risk for suicidal behavior. Language: en |